Nuo Therapeutics, Inc. (AURX)

Capital Expenditure

-$297.08K

TTM · Period ending: · USD

AURX logo

AURX Capital Expenditure

Latest reported-$297.08K
AURX TTM CapEx (-$564.77K → -$297.08K)
High-resolution chart · PNG

AURX capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Nuo Therapeutics, Inc. Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-297,083
-45,723
-274,760
-231,555
-382,413
-384,846
-154,962
-154,962
-6,001
-1,901
-7,244
-11,893
-13,800
-53,487
-59,992
-55,343
-51,535
-11,848
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
532,355
532,355
532,355
532,355
-427,355
-532,355
-532,355
-698,172
-544,317
-572,566
-573,046
-482,962
-359,786
-539,859
-726,430
-750,697
-951,806
-1,372,488
-1,911,744
-2,087,562
-1,800,998
-1,066,994
-340,687
-66,430
-746,860
-699,773
-699,773
-698,212
78,511
27,474
27,474
0
-47,915
-98,945
-101,297
-87,013
-70,522
-15,542
-13,190
0
0
0
0
0
0
0
0
0
-25,418
-47,763
-54,521
-56,563
-31,145
-20,453
-13,695
-11,653
-189,362
-276,147
-298,271
-304,871
-127,162
-28,724
-6,600
-38,883
-127,445
-372,472
-459,451
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.